# to Assess the Safety of Ga68-Dolacga Injection in Healthy Volunteers

> **NCT03908957** · PHASE1 · COMPLETED · sponsor: **National Atomic Research Institute, Taiwan** · enrollment: 12 (actual)

## Conditions studied

- Safety Issues

## Interventions

- **DRUG:** Ga68-Dolacga Injection

## Key facts

- **NCT ID:** NCT03908957
- **Lead sponsor:** National Atomic Research Institute, Taiwan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-12
- **Primary completion:** 2019-08-09
- **Final completion:** 2019-08-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03908957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03908957, "to Assess the Safety of Ga68-Dolacga Injection in Healthy Volunteers". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03908957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*